2AH-12861-90858
3 vaccinations
1 coded response
23 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 019 / MA
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-03-20
Registered in v-safe
- 2021-03-20
- 2021-03-21
- 2021-03-24
- 2021-03-29
-
2021-04-05
Dose 2 — Pfizer-BioNTech
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Muscle or body aches, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-04-12
- 2021-04-21
- 2021-04-28
- 2021-05-03
- 2021-05-20
- 2021-07-05
- 2021-10-04
-
2021-10-05
Dose 3 — Pfizer-BioNTech
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Nausea, Diarrhea, Abdominal painAdult check-in
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-11-02
- 2022-01-04
-
2022-04-05
Survey response — 6 months, dose 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-04-05
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-07
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | |
| 2 | 2021-04-05 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-05 | Successful 2022-04-07 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 11 — 6 months, dose 3
Symptoms: Runny nose and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release